Detalles de la búsqueda
1.
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia.
Diabetes Obes Metab
; 25(6): 1557-1565, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749303
2.
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial.
Diabetes Obes Metab
; 24(2): 257-267, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643020
3.
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
BMC Endocr Disord
; 19(1): 78, 2019 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31337371
4.
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
J Diabetes Sci Technol
; : 19322968231197423, 2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37671755
5.
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
Diabetes Technol Ther
; 24(9): 643-654, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467938
6.
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
Clin Endocrinol (Oxf)
; 71(4): 500-6, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19094067
7.
Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
PLoS One
; 9(1): e83758, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24400077
8.
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
Front Neuroenergetics
; 5: 2, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23543638
9.
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
J Cereb Blood Flow Metab
; 32(12): 2146-52, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22929437
10.
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.
Diabetes
; 57(2): 325-31, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17991759
Resultados
1 -
10
de 10
1
Próxima >
>>